Home
>
National Drug Code (NDC)
>
Erythrocin Stearate
Erythrocin Stearate - 0179-0105-70 - (ERYTHROMYCIN STEARATE)
Drug Information of Erythrocin Stearate
| Product NDC: | 0179-0105 |
| Proprietary Name: | Erythrocin Stearate |
| Non Proprietary Name: | ERYTHROMYCIN STEARATE |
| Active Ingredient(s): | 250 mg/1 & nbsp; ERYTHROMYCIN STEARATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Erythrocin Stearate
| Product NDC: | 0179-0105 |
| Labeler Name: | KAISER FOUNDATION HOSPITALS |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA060359 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120106 |
Package Information of Erythrocin Stearate
| Package NDC: | 0179-0105-70 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOX, UNIT-DOSE (0179-0105-70) |
NDC Information of Erythrocin Stearate
| NDC Code | 0179-0105-70 |
| Proprietary Name | Erythrocin Stearate |
| Package Description | 30 TABLET, FILM COATED in 1 BOX, UNIT-DOSE (0179-0105-70) |
| Product NDC | 0179-0105 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ERYTHROMYCIN STEARATE |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120106 |
| Marketing Category Name | ANDA |
| Labeler Name | KAISER FOUNDATION HOSPITALS |
| Substance Name | ERYTHROMYCIN STEARATE |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |
